Nuveen, based in New York, is the real estate investment arm of TIAA, with origins tracing back to The John Nuveen Company founded in 1898. Renamed Nuveen Real Estate in 2013, it expanded through its integration with TIAA’s real assets platform, today overseeing approximately $142?billion in AUM as of June?2025. The firm pursues a multi-strategy approach across core, value-add, opportunistic, and debt investments, spanning both public and private markets. Nuveen invests across major commercial real estate classes — including industrial, office, retail, multifamily, healthcare, and alternatives like life sciences — while also being active in real estate debt. Its investment strategy emphasizes structural trends, bottom-up market research, local and global expertise, and sector diversification to optimize returns and mitigate risk. Its core geographic focus is split among the U.S., Europe, and Asia-Pacific, with significant exposure in key U.S. urban centers such as New York, Chicago, and Dallas—accounting for more than half its portfolio —highlighting potential regional concentration risks. Top tenants in its private retail and healthcare portfolios include staple names like Trader Joe’s and CVS Health, which contribute notable rental revenue and bolster both occupancy and income stability. In its public strategies, holdings in REITs such as Welltower, Prologis, Equinix, Digital Realty, and American Tower are significant contributors. Nuveen continuously adjusts its strategy, with recent priorities including grocery-anchored retail, medical office buildings (MOBs), and life sciences, launching a large-scale healthcare portfolio and a U.S. strategic debt fund in recent years. The firm’s diversified global footprint and sector focus fortify its position as a leading institutional real estate manager.